Literature DB >> 34889413

Diagnosis and therapeutic decision-making for the neutropenic patient.

James A Connelly1, Kelly Walkovich2.   

Abstract

Determining the cause of a low neutrophil count in a pediatric or adult patient is essential for the hematologist's clinical decision-making. Fundamental to this diagnostic process is establishing the presence or lack of a mature neutrophil storage pool, as absence places the patient at higher risk for infection and the need for supportive care measures. Many diagnostic tests, eg, a peripheral blood smear and bone marrow biopsy, remain important tools, but greater understanding of the diversity of neutropenic disorders has added new emphasis on evaluating for immune disorders and genetic testing. In this article, a structure is provided to assess patients based on the mechanism of neutropenia and to prioritize testing based on patient age and hypothesized pathophysiology. Common medical quandaries including fever management, need for growth factor support, risk of malignant transformation, and curative options in congenital neutropenia are reviewed to guide medical decision-making in neutropenic patients.
Copyright © 2021 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2021        PMID: 34889413      PMCID: PMC8791128          DOI: 10.1182/hematology.2021000284

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  86 in total

1.  Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.

Authors:  Philip S Rosenberg; Cornelia Zeidler; Audrey A Bolyard; Blanche P Alter; Mary A Bonilla; Laurence A Boxer; Yigal Dror; Sally Kinsey; Daniel C Link; Peter E Newburger; Akiko Shimamura; Karl Welte; David C Dale
Journal:  Br J Haematol       Date:  2010-04-29       Impact factor: 6.998

2.  Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length.

Authors:  Amanda M Li; Santhosh Thyagu; Dawn Maze; Richard Schreiber; Sandra Sirrs; Sylvia Stockler-Ipsiroglu; Heather Sutherland; Suzanne Vercauteren; Kirk R Schultz
Journal:  Pediatr Hematol Oncol       Date:  2018-04-13       Impact factor: 1.969

3.  Two cases of cyclic neutropenia with acquired CSF3R mutations, with 1 developing AML.

Authors:  Maksim Klimiankou; Sabine Mellor-Heineke; Olga Klimenkova; Elisa Reinel; Murat Uenalan; Siarhei Kandabarau; Julia Skokowa; Karl Welte; Cornelia Zeidler
Journal:  Blood       Date:  2016-03-30       Impact factor: 22.113

4.  The Risk of Serious Bacterial Infection in Neutropenic Immunocompetent Febrile Children.

Authors:  Assaf A Barg; Eran Kozer; Yair Mordish; Tsilia Lazarovitch; Iris Kventsel; Michael Goldman
Journal:  J Pediatr Hematol Oncol       Date:  2015-08       Impact factor: 1.289

5.  Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry.

Authors:  Kasiani C Myers; Audrey Anna Bolyard; Barbara Otto; Trisha E Wong; Amanda T Jones; Richard E Harris; Stella M Davies; David C Dale; Akiko Shimamura
Journal:  J Pediatr       Date:  2013-12-31       Impact factor: 4.406

6.  Predictive model for serious bacterial infections among infants younger than 3 months of age.

Authors:  R G Bachur; M B Harper
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

7.  Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome.

Authors:  Jean Donadieu; Odile Fenneteau; Blandine Beaupain; Sandrine Beaufils; Florence Bellanger; Nizar Mahlaoui; Anne Lambilliotte; Nathalie Aladjidi; Yves Bertrand; Valérie Mialou; Christine Perot; Gérard Michel; Fanny Fouyssac; Catherine Paillard; Virginie Gandemer; Patrick Boutard; Jacques Schmitz; Alain Morali; Thierry Leblanc; Christine Bellanné-Chantelot
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

8.  Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology.

Authors:  M Dungarwalla; J C W Marsh; J A Tooze; G Lucas; W Ouwehand; R Pettengell; C E Dearden; E C Gordon Smith; M O Elebute
Journal:  Ann Hematol       Date:  2006-11-23       Impact factor: 3.673

Review 9.  How does preeclampsia affect neonates? Highlights in the disease's immunity.

Authors:  Lina R Marins; Leonardo B Anizelli; Mariana D Romanowski; Ana L Sarquis
Journal:  J Matern Fetal Neonatal Med       Date:  2017-11-20

10.  Severe chronic primary neutropenia in adults: report on a series of 108 patients.

Authors:  Flore Sicre de Fontbrune; Aline Moignet; Blandine Beaupain; Felipe Suarez; Lionel Galicier; Gérard Socié; Bruno Varet; Paul Coppo; Marc Michel; Cécile Pautas; Eric Oksenhendler; Etienne Lengline; Louis Terriou; Philippe Moreau; Sylvain Chantepie; Nicole Casadevall; Jean Marie Michot; Martine Gardembas; Mauricette Michallet; Laure Croisille; Marie Audrain; Christine Bellanné-Chantelot; Jean Donadieu; Thierry Lamy
Journal:  Blood       Date:  2015-08-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.